INTERNATIONAL PATENT: SHENZHEN HAOSHI BIOTECHNOLOGY CO., LTD, 深圳豪石生物科技有限公司 FILES APPLICATION FOR "USE OF GPRC5D SINGLE-DOMAIN ANTIBODY AND HUMANIZED ANTIBODY THEREOF IN CONSTRUCTION OF CAR-T CELL"
GENEVA, May 18 -- SHENZHEN HAOSHI BIOTECHNOLOGY CO., LTD (Building 2 Floor 7, Innovation Wisdomport, No.155 Hongtian Road, Xinqiao Street, Bao'an DistrictShenzhen, Guangdong 518104), 深圳豪石生物科技有限公司 (中国广东省深圳市宝安区新桥街道黄埔社区洪田路155号创新智慧港2栋7层) filed a patent application (PCT/CN2025/132816) for "USE OF GPRC5D SINGLE-DOMAIN ANTIBODY AND HUMANIZED ANTIBODY THEREOF IN CONSTRUCTION OF CAR-T CELL" on Nov 05, 2025. With publication no. WO/2026/098523, the details relat...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.